Inheritance in erythropoietic protoporphyria: A common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation

被引:111
作者
Gouya, L [1 ]
Puy, H [1 ]
Lamoril, J [1 ]
Da Silva, V [1 ]
Grandchamp, B [1 ]
Nordmann, Y [1 ]
Deybach, JC [1 ]
机构
[1] Hop Louis Mourier, Fac Xavier Bichat, Ctr Francais Porphyries, INSERM,U409, F-92701 Colombes, France
关键词
D O I
10.1182/blood.V93.6.2105.406k28_2105_2110
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Erythropoietic protoporphyria (EPP) is a rare autosomal dominant disorder of heme biosynthesis characterized by partial decrease in ferrochelatase (FECH; EC 4.99.1.1) activity with protoporphyrin overproduction and consequent painful skin photosensitivity and rarely liver disease. EPP is normally inherited in an autosomal dominant pattern with low clinical penetrance; the many different mutations that have been identified are restricted to one FECH allele, with the other one being free of any mutations. However, clinical manifestations of dominant EPP cannot be simply a matter of FECH haploinsufficiency, because patients have enzyme levels that are lower than the expected 50%. From RNA analysis in one family with dominant EPP, we recently suggested that clinical expression required coinheritance of a normal FECH allele with low expression and a mutant FECH allele. We now show that (1) coinheritance of a FECH gene defect and a wild-type low-expressed allele is generally involved in the clinical expression of EPP; (2) the low-expressed allelic variant was strongly associated with a partial 5' haplotype [-251G IVS1-23T IVS2 mu satA9] that may be ancestral and was present in an estimated 10% of a control group of Caucasian origin; and (3) haplotyping allows the absolute risk of developing the disease to be predicted for those inheriting FECH EPP mutations. EPP may thus be considered as an inherited disorder that does not strictly follow recessive or dominant rules. It may represent a model for phenotype modulation by mild variation in expression of the wild-type allele in autosomal dominant diseases. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:2105 / 2110
页数:6
相关论文
共 28 条
[1]   SP-ALPHA-V/41 - A COMMON SPECTRIN POLYMORPHISM AT THE ALPHA-IV-ALPHA-V DOMAIN JUNCTION - RELEVANCE TO THE EXPRESSION LEVEL OF HEREDITARY ELLIPTOCYTOSIS DUE TO ALPHA-SPECTRIN VARIANTS LOCATED IN TRANS [J].
ALLOISIO, N ;
MORLE, L ;
MARECHAL, J ;
ROUX, AF ;
DUCLUZEAU, MT ;
GUETARNI, D ;
POTHIER, B ;
BAKLOUTI, F ;
GHANEM, A ;
KASTALLY, R ;
DELAUNAY, J .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) :2169-2177
[2]   HEME SYNTHETASE DEFICIENCY IN HUMAN PROTOPORPHYRIA - DEMONSTRATION OF DEFECT IN LIVER AND CULTURED SKIN FIBROBLASTS [J].
BONKOWSKY, HL ;
BLOOMER, JR ;
EBERT, PS ;
MAHONEY, MJ .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 56 (05) :1139-1148
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]  
DEYBACH JC, 1986, PORPHYRINS PROPHYRIA, P193
[5]   Clonality analysis of hematopoiesis in essential thrombocythemia: Advantages of studying T lymphocytes and platelets [J].
ElKassar, N ;
Hetet, G ;
Briere, J ;
Grandchamp, B .
BLOOD, 1997, 89 (01) :128-134
[6]  
Gouya L, 1996, AM J HUM GENET, V58, P292
[7]  
HENRIKSSON M, 1995, SCAND J CLIN LAB INV, V55, P223
[8]   Mutations in Hirschsprung disease: When does a mutation contribute to the phenotype [J].
Hofstra, RMW ;
Osinga, J ;
Buys, CHCM .
EUROPEAN JOURNAL OF HUMAN GENETICS, 1997, 5 (04) :180-185
[9]  
KAPPAS A, 1995, METABOLIC MOL BASES, P2139
[10]   HUMAN ERYTHROPOIETIC PROTOPORPHYRIA - 2-POINT MUTATIONS IN THE FERROCHELATASE GENE [J].
LAMORIL, J ;
BOULECHFAR, S ;
DEVERNEUIL, H ;
GRANDCHAMP, B ;
NORDMANN, Y ;
DEYBACH, JC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 181 (02) :594-599